Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending June 2012. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details specific share acquisitions made on June 13, 2012, through the Company's ShareReward Plan at a price of 1460.47 pence per Ordinary Share. The transactions involved personal contributions and matching company contributions for the following individuals:
- Sir Andrew Witty: Acquired 9 shares (personal) and 9 shares (company match).
- Mr S Dingemans: Acquired 9 shares (personal) and 9 shares (company match).
- Mr S M Bicknell: Acquired 9 shares (personal) and 9 shares (company match).
- Mr E J Gray: Acquired 9 shares (personal) and 9 shares (company match).
- Mr D S Redfern: Acquired 9 shares (personal) and 9 shares (company match).
- Ms C Thomas: Acquired 9 shares (personal) and 9 shares (company match).
- Mr P C Thomson: Acquired 7 shares (personal) and 7 shares (company match).
- Dr P J T Vallance: Acquired 8 shares (personal) and 8 shares (company match).
- Mrs V A Whyte: Acquired 9 shares (personal) and 9 shares (company match).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the aforementioned share transactions in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Investor Verification Points
- Verify the share price of 1460.47 pence per Ordinary Share on June 13, 2012.
- Confirm the total number of shares acquired by each listed director and executive under the ShareReward Plan.
- Review the company's ShareReward Plan terms to understand the matching contribution structure.
- Note that this filing contains no financial performance data for the period.